Intuit Inc Expands Enterprise Suite to Target MidMarket Business Growth
Charles Schwab CEO Prioritizes Wealth Building Over Speculative Trends to Drive Customer Growth
Bitcoin Dips Below 76000 as Market Faces Weekly Loss Amid Liquidations and Rate Uncertainty
April Jobs Report Expected to Show Cooling Yet Resilient Labor Market
ATT CEO Highlights Growing Demand for Skilled BlueCollar Workers in AIDriven Economy
Indian Billionaires Accelerate Overseas Acquisitions as Domestic Growth Moderates
ZS Q1 2026 Earnings EPS Surprises to the Upside Amidst Growth Focus
QH Q4 2021 Earnings Staggering EPS Miss Exposes Deep Operational Challenges
HIG Q1 2026 Earnings Profit Falls Short of Estimates Shares Flat
Diamond Hill Investment Group Inc DHIL Q1 2025 Earnings Solid EPS Report Amid Quiet Market Reaction
CLB Q1 2026 Earnings EPS Miss Weighs on Results Stock Gains Despite Disappointing Profitability
PPL Q1 2026 Earnings EPS Beats Estimates Utility Operations Drive Steady Performance
Talkspace Consolidates Near Support as TALK Holds at 519
Champion Homes SKY Rallies 208 as Builders Sector Momentum Builds
Nuveen Municipal Credit Opportunities Fund NMCO Edges Higher Amid Steady Income Demand
Charles Schwab SCHW Holds Steady Near Support Amid Modest Decline
PagerDuty PD Breaks Above Recent Range After 348 Surge
Nvidia Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Shift
CALX Q1 2026 Earnings EPS Matches Estimates Stock Rises 211
Amphastar Pharmaceuticals AMPH Gains 138 as Stock Consolidates Near Key Resistance
MSGS Q1 2026 Earnings EPS Falls Well Below Estimates as Stock Holds Steady
Almonty Industries Q1 2026 Earnings EPS Misses Estimates as Loss Widens Shares Decline
Redwood Trust Inc 900 Senior Notes Due 2029 RWTO Q1 2026 Earnings BottomLine Miss Underscores NearTerm Headwinds
SFL Q1 2026 Earnings Stunning EPS Surprise of 1880 Despite Negative Stock Reaction
Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns
OLLI Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Dips
OnKure Therapeutics OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline